Literature DB >> 19156021

Spanish adaptation of the Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39).

M C Lata-Caneda1, M Piñeiro-Temprano, I García-Fraga, I García-Armesto, J R Barrueco-Egido, R Meijide-Failde.   

Abstract

AIM: The stroke and aphasia quality of life scale-39 is an interviewer administered questionnaire that has been developed and validated in the United Kingdom to be applied to patients with chronic aphasia as a consequence of a stroke. The objective of this article was to translate the Stroke and Aphasia Quality of Life-39 Scale (SAQOL-39) into Spanish language, and evaluate its acceptability and reliability.
METHODS: The cross-cultural adaptation of the SAQOL-39 into Spanish was carried out by following the translation and back-translation method. Twenty three patients with long-term aphasia due to stroke were tested. The patients were interviewed twice in a period from 2 to 12 days. The acceptability of the Spanish SAQOL-39 was evaluated by examining the floor/ceiling effects and the missing data. The reliability was assessed by Cronbach's alpha (internal consistence) and intraclass correlation coefficients (test-retest reliability) for the overall scale and its subdomains.
RESULTS: There were no difficulties to translate the original version into Spanish. There was good acceptability demonstrated by minimal missing data and floor/ceiling effects. Test-retest reliability for the overall score, and the subscales scores was 0.949 (0.854-0.944). Internal consistency analysis by Cronbach's a was 0.950 (0.851-0.900).
CONCLUSIONS: This small scale study provided preliminary evidence for the acceptability and reliability of the Spanish version of the SAQOL-39. Further testing in larger samples is needed to evaluate the validity of the scale, its sensitivity to change and to confirm its reliability.

Entities:  

Mesh:

Year:  2009        PMID: 19156021

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  7 in total

1.  Adaptation and validation of stroke-aphasia quality of life (SAQOL-39) scale to Malayalam.

Authors:  Ria Raju; Gopee Krishnan
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

2.  Adaptation and validation of stroke-aphasia quality of life (SAQOL-39) scale to Hindi.

Authors:  Ishita H Mitra; Gopee Krishnan
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

3.  Cholinergic Potentiation and Audiovisual Repetition-Imitation Therapy Improve Speech Production and Communication Deficits in a Person with Crossed Aphasia by Inducing Structural Plasticity in White Matter Tracts.

Authors:  Marcelo L Berthier; Irene De-Torres; José Paredes-Pacheco; Núria Roé-Vellvé; Karl Thurnhofer-Hemsi; María J Torres-Prioris; Francisco Alfaro; Ignacio Moreno-Torres; Diana López-Barroso; Guadalupe Dávila
Journal:  Front Hum Neurosci       Date:  2017-06-14       Impact factor: 3.169

4.  Cultural Adaptation and Preliminary Validation of the Proxy-Rated Sinhala Version of the Stroke and Aphasia Quality of Life Generic Scale-39.

Authors:  P N Kariyawasam; K D Pathirana; D C Hewage; Rda Dissanayake
Journal:  J Cent Nerv Syst Dis       Date:  2020-05-27

5.  Stroke and aphasia quality of life scale in Kannada-evaluation of reliability, validity and internal consistency.

Authors:  S Kiran; Gopee Krishnan
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

6.  Quality of life measurement and outcome in aphasia.

Authors:  Simona Spaccavento; Angela Craca; Marina Del Prete; Rosanna Falcone; Antonia Colucci; Angela Di Palma; Anna Loverre
Journal:  Neuropsychiatr Dis Treat       Date:  2013-12-17       Impact factor: 2.570

7.  Early Occupational Therapy Intervention in the Hospital Discharge after Stroke.

Authors:  Patricia García-Pérez; María Del Carmen Rodríguez-Martínez; José Pablo Lara; Carlos de la Cruz-Cosme
Journal:  Int J Environ Res Public Health       Date:  2021-12-07       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.